Yazılar

Avride Partners with Grubhub to Expand Food Delivery Robots on U.S. Campuses

Autonomous technology startup Avride has announced a partnership with food delivery company Grubhub to expand its fleet of food delivery robots across U.S. college campuses. The initiative aims to address labor shortages, lower delivery costs, and reduce reliance on cars for short-distance food transport.

Avride has already deployed its first fleet of 100 robots at Ohio State University, where it also plans to introduce its next-generation models. The university now relies exclusively on robot deliveries and also utilizes robots from other startups, such as Cartken.

“Campuses are almost ideal environments for introducing automation in delivery. They are relatively small areas with a high density of orders, which is where robots perform best,” Avride CEO Dmitry Polishchuk told Reuters. He also noted strong interest from other universities in adopting robotic delivery solutions.

Avride joins a growing number of companies, including Serve Robotics, in partnering with ride-hailing and delivery platforms to scale autonomous food delivery. In October, Avride announced a partnership with Uber for food delivery and robotaxi services, further expanding its presence in the autonomous mobility sector.

Founded in 2017 and headquartered in Austin, Texas, Avride has completed over 200,000 deliveries across five countries. The company was previously part of Yandex’s self-driving division but became independent following a corporate restructuring last year.

 

Rising Pancreatic Cancer Cases in Under-50 Adults Highlight Low Awareness Levels

A recent survey conducted by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) has revealed a troubling gap in awareness about pancreatic cancer among adults under 50. Despite a rising number of pancreatic cancer diagnoses in younger individuals, the survey found that more than half of the respondents failed to recognize the early warning signs of the disease. Furthermore, about one-third mistakenly believed that pancreatic cancer only affected older adults. This lack of awareness extends to preventive measures as well, with many unaware of how lifestyle changes could reduce the risk of developing this deadly cancer.

Rising Diagnoses in People Under 50 Spark Concerns

The increase in pancreatic cancer diagnoses among younger individuals has raised alarms among health experts. Dr. Zobeida Cruz-Monserrate, co-leader of the Molecular Carcinogenesis and Chemoprevention Programme at OSUCCC—James, pointed out that pancreatic cancer rates in people under 50 have been climbing by about 1% annually. This shift in the age demographics of the disease is both unusual and concerning, as pancreatic cancer is notorious for being diagnosed at advanced stages, when treatment options are far less effective. The lack of early detection methods contributes to the grim prognosis associated with the disease.

Factors Influencing Pancreatic Cancer Risk

Genetics account for approximately 10% of pancreatic cancer cases, but lifestyle choices play a much larger role in determining an individual’s risk. According to the American Cancer Society, factors such as obesity significantly increase one’s lifetime risk of pancreatic cancer, with obesity linked to a 20% increase in risk. Dr. Cruz-Monserrate stressed that maintaining a healthy weight, staying physically active, and moderating alcohol consumption are key lifestyle adjustments that can not only lower the risk of pancreatic cancer but also improve overall health. These preventive measures offer a practical approach to combating the rising threat of the disease.

The findings from this survey underscore the urgent need for increased awareness and education on pancreatic cancer, particularly among younger adults. Public health initiatives must focus on the importance of recognizing symptoms early and promoting healthy lifestyle choices. With more attention on prevention and early detection, the burden of pancreatic cancer could be reduced, potentially saving lives in future generations.